April 2023 numbers include the privately insured, such as Medicare Advantage.
National telehealth use decreased 5.4% in April 2023, from 5.6% of medical claim lines in March to 5.3% in April, according to FAIR Health's Monthly Telehealth Regional Tracker. The decrease followed an increase in March 2023. In April, telehealth utilization also decreased in all four US census regions—the Midwest (4.7%), Northeast (6.3%), South (6.8%), and West (6.4%). The data represent the privately insured population, including Medicare Advantage and excluding Medicare Fee-for-Service and Medicaid.
Mental health conditions, the top-ranking telehealth diagnosis nationally and in every region, rose from 67.4% of telehealth claim lines nationally in March 2023 to 68.4% in April, marking the fourth straight month of national increases.
The percentage of telehealth claim lines for the second-place diagnosis, acute respiratory diseases and infections, decreased nationally in April, falling from 3.2% in March to 2.7% in April. This was the fourth consecutive national monthly decrease for this diagnosis.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.